Follow
Dr. Surendra Gulla
Dr. Surendra Gulla
Postdoctoral Associate
Verified email at buffalo.edu
Title
Cited by
Cited by
Year
Potential therapeutic applications of C-phycocyanin
SM Bannu, D Lomada, S Gulla, T Chandrasekhar, P Reddanna, ...
Current drug metabolism 20 (12), 967-976, 2019
362019
Recent advances in nanoparticles-based strategies for cancer therapeutics and antibacterial applications
S Gulla, D Lomada, VVSS Srikanth, MV Shankar, KR Reddy, S Soni, ...
Methods in microbiology 46, 255-293, 2019
342019
Titanium dioxide nanotubes conjugated with quercetin function as an effective anticancer agent by inducing apoptosis in melanoma cells
S Gulla, D Lomada, PB Araveti, A Srivastava, MK Murikinati, KR Reddy, ...
Journal of nanostructure in chemistry 11, 721-734, 2021
292021
Synthesis of titanium dioxide nanotubes (TNT) conjugated with quercetin and its in vivo antitumor activity against skin cancer
S Gulla, VC Reddy, PB Araveti, D Lomada, A Srivastava, MC Reddy, ...
Journal of Molecular Structure 1249, 131556, 2022
152022
Role of thymus in health and disease
S Gulla, MC Reddy, VC Reddy, S Chitta, M Bhanoori, D Lomada
International Reviews of Immunology 42 (5), 347-363, 2023
102023
Role of prostaglandins in multiple sclerosis
S Gulla, D Lomada, A Lade, R Pallu, MC Reddy
Current Pharmaceutical Design 26 (7), 730-742, 2020
52020
Holy basil: A potential herbal source for therapeutic applications
L Dakshayani, N Merchant, S Smitha, G Surendra, TG Reddy, D Mamatha, ...
Current Trends in Biotechnology and Pharmacy 15 (1), 87-100, 2021
32021
Anti‐Inflammatory and Antioxidant Activity of Titanium Dioxide Nanotubes Conjugated with Quercetin
D Lomada, S Gulla, MC Reddy
Chemistry & Biodiversity 20 (11), e202301188, 2023
12023
Posttranslational modification in glucocorticoid receptor in treatment resistant prostate cancers
S Gulla, E Gardner, SS Sundar, P Jaiswal, N Gao, L Bennet, S Conzen, ...
Cancer Research 84 (6_Supplement), 1953-1953, 2024
2024
Abstract B003: EVI1 oncogenic role in non-canonical AR driven lethal prostate cancer
S Gulla, JE Bard, DJ VanderWeele, K Kelly, R Adelaiye-Ogala
Cancer Research 83 (11_Supplement), B003-B003, 2023
2023
Alterations in hormone receptors regulome following response to kinase inhibitors in lethal prostate cancer
RM Adelaiye-Ogala, S Gulla, JE Bard, DJ VanderWeele, K Kelly
Cancer Research 83 (7_Supplement), 3859-3859, 2023
2023
EVI1 oncogenic role in non-canonical AR driven lethal prostate cancer
S Gulla, JE Bard, DJ VanderWeele, K Kelly, R Adelaiye-Ogala
Cancer Research 83 (7_Supplement), 3989-3989, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–12